Chronic Spontaneous Urticaria

Also known as: Spontaneous Urticaria, Chronic / Chronic idiopathic urticaria / Chronic idiopathic urticaria (disorder)

DrugDrug NameDrug Description
DB11591BilastineA peripheral histamine H1-antagonist used to treat seasonal allergic rhinitis and chronic spontaneous urticaria.
DrugDrug NamePhaseStatusCount
DB06612Mepolizumab0Active Not Recruiting1
DB11856Ligelizumab1Terminated1
DB00043Omalizumab1Recruiting1
DB18136Briquilimab1 / 2Recruiting1
DB12023Benralizumab2Terminated1
DB09061Cannabidiol2Unknown Status1
DB12159Dupilumab2Completed1
DB11856Ligelizumab2Completed3
DB16728Lirentelimab2Active Not Recruiting1
DB00043Omalizumab2Completed2
DB00043Omalizumab2Recruiting1
DB17709Rilzabrutinib2Active Not Recruiting1
DB15090Tezepelumab2Completed1
DB15227Tirabrutinib2Withdrawn1
DB00041Aldesleukin2 / 3Not Yet Recruiting1
DB00043Omalizumab2 / 3Completed1
DB11105Benzalkonium3Not Yet Recruiting1
DB12159Dupilumab3Active Not Recruiting1
DB12159Dupilumab3Recruiting1
DB06282Levocetirizine3Completed1
DB11856Ligelizumab3Completed3
DB11856Ligelizumab3Terminated1
DB00043Omalizumab3Completed6
DB00043Omalizumab3Not Yet Recruiting2
DB00043Omalizumab3Recruiting1
DB16852Remibrutinib3Active Not Recruiting1
DB16852Remibrutinib3Completed3
DB16852Remibrutinib3Recruiting3
DB06282Levocetirizine4Recruiting1
DB00455Loratadine4Not Yet Recruiting1
DB00043Omalizumab4Completed1
DB00043Omalizumab4Recruiting1
DB00302Tranexamic acid4Recruiting1
DB11856LigelizumabNot AvailableNo Longer Available1
DB16852RemibrutinibNot AvailableAvailable1